Shenzhen Kangtai Biological Products Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 12.99%

Shenzhen Kangtai Biological Products Co Ltd (300601) has an Asset Resilience Ratio of 12.99% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shenzhen Kangtai Biological Products Co working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.81 Billion

≈ $264.77 Million USD Cash + Short-term Investments

Total Assets

CN¥13.93 Billion

≈ $2.04 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300601 asset base.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Kangtai Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Shenzhen Kangtai Biological Products Co for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.81 Billion	12.99%
Total Liquid Assets	CN¥1.81 Billion	12.99%

Asset Resilience Insights

Moderate Liquidity: Shenzhen Kangtai Biological Products Co Ltd has 12.99% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Kangtai Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Kangtai Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Shenzhen Kangtai Biological Products Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Kangtai Biological Products Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.98%	CN¥1.69 Billion ≈ $247.13 Million	CN¥14.10 Billion ≈ $2.06 Billion	-2.95pp
2024-12-31	14.93%	CN¥2.17 Billion ≈ $318.13 Million	CN¥14.56 Billion ≈ $2.13 Billion	+14.26pp
2023-12-31	0.66%	CN¥100.02 Million ≈ $14.64 Million	CN¥15.09 Billion ≈ $2.21 Billion	-2.53pp
2022-12-31	3.20%	CN¥440.83 Million ≈ $64.51 Million	CN¥13.79 Billion ≈ $2.02 Billion	-1.93pp
2021-12-31	5.13%	CN¥725.57 Million ≈ $106.17 Million	CN¥14.15 Billion ≈ $2.07 Billion	-17.36pp
2020-12-31	22.49%	CN¥2.16 Billion ≈ $315.37 Million	CN¥9.58 Billion ≈ $1.40 Billion	+17.96pp
2017-12-31	4.52%	CN¥100.00 Million ≈ $14.63 Million	CN¥2.21 Billion ≈ $323.50 Million	+2.85pp
2016-12-31	1.67%	CN¥26.80 Million ≈ $3.92 Million	CN¥1.60 Billion ≈ $234.26 Million	+0.17pp
2015-12-31	1.50%	CN¥20.00 Million ≈ $2.93 Million	CN¥1.33 Billion ≈ $195.18 Million	+0.68pp
2014-12-31	0.82%	CN¥11.00 Million ≈ $1.61 Million	CN¥1.34 Billion ≈ $196.39 Million	-0.49pp
2013-12-31	1.31%	CN¥14.50 Million ≈ $2.12 Million	CN¥1.11 Billion ≈ $161.97 Million	--

pp = percentage points

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.99 Billion

CN¥13.57 Billion CNY

Market Cap Rank

#6236 Global

#1220 in China

Share Price

CN¥12.15

Change (1 day)

+3.23%

52-Week Range

CN¥10.97 - CN¥17.50

All Time High

CN¥148.10